Some analysts believe there is still going to be a substantial market for hcv treatments in 2020:
"Merck has its own blockbuster ambitions--analysts have pegged 2020 sales at $2 billion-plus".
Maybe this explains the recent buying by Sabby.![]()
Add to My Watchlist
What is My Watchlist?